<DOC>
	<DOCNO>NCT00838968</DOCNO>
	<brief_summary>The purpose study determine whether interferon-alpha effective treatment p48 Positive patient HCC curative resection .</brief_summary>
	<brief_title>The Efficiency Postoperative Interferon-alpha Treatment p48 Positive Patients With Hepatocellular Carcinoma</brief_title>
	<detailed_description>BACKGROUND : Postoperative interferon-alpha ( IFN-alpha ) therapy improve survival patient hepatocellular carcinoma ( HCC ) . P48 predictive marker outcome postoperative interferon-alpha treatment patient HCC . Our study identify Efficiency Postoperative IFN-Alpha Treatment p48 Positive Patients With HCC . METHODS : An immunohistochemical study P48 perform specimen collect patient underwent curative resection HCC . These patient p48 Positive randomize divided treatment group receive postoperative IFN-alpha therapy comparison group receive . Besides side effect , overall survival rate disease-free survival rate observe . Anticipated RESULTS : IFN alpha treatment improve overall survival p48 Positive patient HCC curative resection , probably postpone recurrence .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Patients p48 Positive underwent curative resection HCC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>interferon-alpha</keyword>
	<keyword>p48</keyword>
</DOC>